Task: Answer the multiple-choice question.
Question: Which compound exhibits a -2.372% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COc1ccccc1Oc1c(C)oc2cc(OC(=O)N(C)C)ccc2c1=O
b.) COC(=O)c1ccc(NC(=O)CCN2C(=O)C3CC=CCC3C2=O)cc1
Answer: b. COC(=O)c1ccc(NC(=O)CCN2C(=O)C3CC=CCC3C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(NC(=O)CCN2C(=O)C3CC=CCC3C2=O)cc1
COC(=O)c1ccc(NC(=O)CCN2C(=O)C3CC=CCC3C2=O)cc1
methyl 4-[3-(1,3-dioxo-3a,4,7,7a-tetrahydroisoindol-2-yl)propanoylamino]benzoate